The Longevity Audit: What to Check Before You Optimize
A longevity audit starts with triage: symptoms and known abnormal results first; then fatal preventable risks like blood pressure, ApoB/LDL/Lp(a), tobacco, metabolic risk, cancer screening, kidney/liver risk, and targeted vascular screening; then asymmetric risks and physiologic reserve. Biomarkers, wearables, hormones, and experiments earn their place only when they change decisions.
Start with triage
Symptoms, red flags, and overdue abnormal results are not optimization projects. They need medical evaluation and follow-through.
Close fatal loops first
Blood pressure, ApoB/LDL/Lp(a), tobacco, metabolic risk, cancer screening, and selective vascular screening usually outrank novelty biomarkers.
Measure only what changes decisions
The best biomarker is not the most obscure one. It is the one that changes what you do next.

Short answer
A longevity audit is health spring cleaning with a triage nurse in the room.
It does not start by alphabetizing supplements or buying a biological-age test. It asks:
What is the most preventable thing most likely to shorten my life or shrink my independence, and have I actually closed that loop?
The order matters: first, follow up symptoms and known abnormal results. Then close the fatal loops: blood pressure, ApoB/LDL/Lp(a), tobacco, metabolic risk, age and risk appropriate cancer screening, kidney/liver risk, and selective vascular screening. Then remove asymmetric risks like alcohol, seat belts, helmets, falls, medication burden, vaccines, and aspirin misuse. Then build reserve through fitness, strength, sleep, nutrition, and social connection.
Only after that should biomarkers, hormones, wearables, genetics, and n=1 experiments move up the list. A CGM, hormone panel, whole-body MRI, rapamycin debate, or biological-age clock may be interesting. It is just lower priority if your blood pressure is uncontrolled, colorectal screening is overdue, ApoB is high and unaddressed, or alcohol is turning sleep into a crime scene.
Why most longevity checklists get the order wrong
A lot of longevity advice is organized by novelty. That is how people end up comparing epigenetic clocks while they do not know their home blood pressure, debating supplement stacks while colon cancer screening is overdue, or wearing three devices while weekend alcohol is wrecking sleep, mood, reflux, and blood pressure.
The problem is not curiosity. The problem is sequence.
A good longevity audit uses this formula:
Priority = absolute risk x preventability x actionability x evidence quality x personalization
That formula pushes boring, measurable, evidence-backed risks above shiny objects. It also keeps the audit personal. A 35-year-old cyclist with a strong family history of early heart disease should not have the same first five priorities as a 68-year-old with falls, insomnia, hypertension, and ten medications.
If spring cleaning had a medical license, it would check the smoke alarms before rearranging the spice drawer.
Where the hallmarks of aging fit

Hallmarks explain the biology. They do not replace the priority order.
The hallmarks of aging are the mechanism map underneath the audit. The 2023 Cell update names twelve, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem-cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis.
That biology matters because it explains why the "boring" levers are not actually boring:
- DNA damage, telomeres, and senescence point toward cancer risk, inherited-risk review, tobacco and UV exposure, infection prevention, and abnormal-test follow-through.
- Nutrient sensing, mitochondria, autophagy, and proteostasis point toward insulin resistance, visceral fat, fitness, muscle, sleep, protein, alcohol, and medication context.
- Inflammation, dysbiosis, altered signaling, and stem-cell exhaustion point toward sleep apnea, oral and infection risk, chronic inflammatory disease, fiber, frailty, bone, recovery, and immune vulnerability.
Hallmarks explain why the basics work. They do not replace the audit order. If a mechanism cannot become a human, measurable, action-changing proxy, it belongs in the research file, not at the top of your weekend checklist.
First: symptoms are not audit items
This guide is for prevention and risk review in people who are generally stable. It is not a substitute for medical care.
If you have chest pain, shortness of breath out of proportion, fainting, new neurologic symptoms, a new severe headache, unexplained weight loss, blood in stool, persistent fevers, abnormal bleeding, new focal weakness, severe depression, suicidal thoughts, or another concerning symptom, do not turn it into a longevity project. Get evaluated.
Same for the things already trying to get your attention: a positive stool test, abnormal mammogram, persistently high blood pressure, rising creatinine, unexplained anemia, abnormal bleeding, or a lab your clinician asked you to repeat.
The first audit question is simple:
Is there already a warning light I am trying to rebrand as optimization?
If yes, start there.
Tier 1: close the fatal loops

If a fatal-risk gate is open, that branch becomes the next action.
These are the conditions and risks that often kill early, silently, or preventably. They usually deserve attention before exotic optimization.
1. Blood pressure: the highest-ROI home metric
Blood pressure is common, silent, measurable, actionable, and easy to measure badly. It drives stroke, heart disease, heart failure, kidney disease, vascular brain injury, and pregnancy-related risk patterns.
Ask: Do I know my usual home blood pressure? Was it measured with the right cuff and technique? If clinic readings are high, was that confirmed at home or with ambulatory monitoring? If it is high, what is the plan?
The USPSTF recommends adult hypertension screening and out-of-office confirmation when appropriate. A large individual participant meta-analysis found about a 10 percent reduction in major cardiovascular events per 5 mm Hg reduction in systolic blood pressure.
If you buy only one home device, make it a validated upper-arm blood pressure cuff. Not sexy. Extremely useful. The cuff does not care about your supplement drawer.
2. Atherogenic lipoproteins: ApoB, LDL-C, non-HDL-C, and Lp(a)
The most common fatal surprise is often not a surprise biologically. It is years of blood pressure, ApoB-containing particles, glucose, nicotine, and family history adding up in the background.
Core questions: What are my LDL-C and non-HDL-C? Do I know ApoB if metabolic risk, high triglycerides, insulin resistance, or discordance is possible? Have I checked Lp(a) once in adulthood? Is there premature ASCVD, stroke, sudden death, or very high cholesterol in my family? Would CAC change a treatment decision, or am I ordering it to feel thorough?
Lp(a) is mostly genetic. A high value can change how aggressively the rest of the risk stack should be managed. CAC can help selected borderline or intermediate-risk adults when the statin decision is uncertain. It is not a universal scan and it is not a moral verdict on your arteries.
3. Tobacco and nicotine exposure
Smoking affects cardiovascular disease, cancer, lung disease, aneurysm risk, bone health, fertility, wound healing, skin, and cognition.
A real audit asks whether you smoke, vape, use nicotine pouches, have secondhand exposure, qualify for lung cancer screening, or have tried evidence-based cessation support. The USPSTF recommends asking all adults about tobacco use and offering behavioral support plus FDA-approved pharmacotherapy for nonpregnant adults when appropriate.
This is one place to be blunt. Combustible tobacco cessation belongs near the top.
4. Metabolic risk: glucose, waist, liver, kidney, and insulin-resistance context
Metabolic risk affects cardiovascular disease, kidney disease, fatty liver, sleep apnea, neuropathy, infections, cancer risk patterns, and cognitive aging.
The minimum audit usually includes A1c and/or fasting glucose by age/risk, waist or another visceral-fat proxy when useful, blood pressure, lipids, triglycerides, HDL-C, liver enzymes, and kidney markers when context supports them.
The USPSTF recommends screening adults 35 to 70 with overweight or obesity for prediabetes and type 2 diabetes, with individualized earlier screening for higher-risk histories. If prediabetes is found, it is not a shrug: the Diabetes Prevention Program showed intensive lifestyle intervention reduced diabetes incidence by 58 percent compared with placebo over about 2.8 years, with metformin reducing incidence by 31 percent.
5. Cancer screening: the right test, the right person, the right interval
Cancer screening is not "scan everything." It is the right test, for the right risk, at the right interval, with a plan if the result is abnormal.
A practical audit checks colorectal screening starting at 45 for average-risk adults; breast screening by age/risk; cervical screening by age and HPV/cytology strategy; annual low-dose CT for adults 50 to 80 with at least 20 pack-years who currently smoke or quit within 15 years; prostate shared decision-making for many men 55 to 69; and skin evaluation based on changing lesions and individual risk.
The point is evidence-based screening with follow-through. Broad tumor markers and whole-body scans can create false alarms, false reassurance, incidental findings, and expensive cascades. A scan is not automatically better because it feels more thorough.
6. Kidney, liver, and selective vascular screening
Kidney and liver disease often sit behind more glamorous risks. For kidney risk, the basics are creatinine/eGFR and urine albumin-creatinine ratio in people with diabetes, hypertension, cardiovascular disease, prior abnormal kidney labs, family history, pregnancy complications, autoimmune disease, or nephrotoxic medication exposure.
For liver risk, ask about alcohol, metabolic risk, viral hepatitis, medications, supplements, and persistent liver enzyme abnormalities. The USPSTF recommends hepatitis C screening for adults 18 to 79.
For aneurysms, be targeted: AAA ultrasound for men 65 to 75 who have ever smoked, selective decisions for some others, and brain aneurysm screening only in high-risk contexts such as multiple affected first-degree relatives, ADPKD, or selected genetic syndromes.
A good audit is not "image everything." It is "screen where finding something is more likely to help than harm."
Tier 2: remove asymmetric risks

Low-friction safeguards can outrank glamorous optimization when the downside prevented is large.
Some risks are obvious enough that longevity people skip them. That is a mistake.
Alcohol is not a longevity intervention
Alcohol affects sleep architecture, blood pressure, atrial fibrillation risk, liver disease, injury risk, mood, reflux, cancer risk, glucose cravings, and medication interactions.
The audit should not ask, "Is red wine actually good for me?" It should ask how many drinks you really have per week, whether they cluster into binges, what happens to sleep/resting heart rate/HRV/BP/mood/reflux/anxiety after drinking, and whether you have breast cancer risk, liver risk, AFib, hypertension, sleep apnea, depression, sedative use, or family history of alcohol use disorder.
The USPSTF recommends screening adults for unhealthy alcohol use and offering brief counseling when risky use is found. The clean longevity message: do not start drinking for health, avoid binge and heavy patterns, and consider a lower-intake experiment if your metrics look worse after alcohol.
Alcohol is not a longevity supplement with a branding problem.
Seat belts, helmets, and exposure-specific safety
If you drive, seat belts matter. If you bike, helmets matter. If you ski, ride motorcycles, use e-bikes, commute while sleep deprived, or drink before risky activities, the audit should reflect your actual exposure.
This is not a moral lecture. It is asymmetric risk math. The NHTSA cites seat belts as reducing fatal injury risk by about 45 percent in front-seat passenger cars and 60 percent in light trucks. A cycling helmet meta-analysis found helmet use associated with lower odds of head injury, serious head injury, facial injury, and fatal head injury.
If you bike daily, your helmet may be doing more for your longevity than your NAD stack.
Falls, fractures, and bone health
Falls are easy to underweight until they happen. A hip fracture, fear of falling, hospitalization, sedating medication, or loss of confidence can shrink independence quickly.
Ask: Have I fallen or nearly fallen? Is balance changing? Do vision or hearing problems increase risk? Are sedating, anticholinergic, blood pressure, sleep, or pain medications contributing? Do I qualify for osteoporosis screening? Am I training strength and balance?
The USPSTF recommends exercise interventions for community-dwelling adults 65 or older at increased risk for falls and osteoporosis screening for women 65 and older, plus younger postmenopausal women at increased risk.
Do not confuse a body-composition DXA with a fracture-risk evaluation. Same machine sometimes, different question.
Medication review, vaccines, aspirin, and other quiet loops
A medication list can be a hidden risk factor. Benzodiazepines, Z-drugs, opioids, gabapentinoids, anticholinergics, NSAIDs, PPIs, duplicates, supplement interactions, and old prescriptions can contribute to falls, confusion, constipation, bleeding, kidney injury, sleep disruption, and sedation.
The task is not "stop your meds." It is "bring the real list and ask what can be simplified safely." Include the supplements. Especially the supplements.
Vaccines are another low-drama prevention loop: influenza, COVID, Tdap/Td, shingles, pneumococcal, RSV, hepatitis B, travel vaccines, and others depending on age and risk. The exact CDC schedule changes, so this is a current-guidance item, not a memorized list.
Aspirin is the reminder that prevention can harm when used casually. It may be individualized for some adults 40 to 59 with elevated cardiovascular risk, but the USPSTF recommends against initiating aspirin for primary prevention at age 60 or older. More prevention is not always better prevention.
Tier 3: build physiologic reserve

Healthspan work becomes personal when the weakest spoke chooses the next move.
Closing fatal loops helps you avoid preventable disease. Building reserve helps you stay functional when life happens.
Cardiorespiratory fitness: how much work can your body do?
Cardiorespiratory fitness is one of the strongest healthspan signals because it integrates the heart, lungs, vessels, muscles, mitochondria, autonomic system, and behavior.
Ask: How much moderate and vigorous activity do I get? Can I climb stairs or hills without disproportionate symptoms? Is my estimated VO2 max, treadmill capacity, or field-test performance improving? Do I have an aerobic base and some higher-intensity work if safe? What is my step-count floor?
Large observational and meta-analytic evidence links higher cardiorespiratory fitness with lower all-cause and cardiovascular mortality. Because much of this evidence is observational, the honest phrasing is "associated with," not magic. But clinically, low fitness is still a very loud signal.
If I could only know one "longevity lab" about someone, I would rather know how much work their body can do than how many supplements they take.
Strength, muscle, grip, and balance
Strength is not vanity. It is how you get off the floor, carry groceries, climb stairs, travel, recover from illness, and reduce fall risk.
Audit resistance training frequency; grip strength, sit-to-stand, loaded carry, dead hang, or another functional proxy; balance and gait; protein adequacy; and lean mass/body composition when it changes the plan.
Grip strength predicts outcomes, but it is not a spell. It is a proxy. Train the person, not just the number.
Nutrition: make it auditable
"Eat healthy" is too vague to audit.
Better questions: How much fiber do I get? Do I get enough protein for age, training, weight loss, or frailty risk? How often do I eat legumes, whole grains, fruits, vegetables, nuts, and minimally processed foods? How much ultra-processed food crowds out nutrient-dense food? What does my diet do to ApoB, BP, A1c, liver enzymes, waist, satiety, and digestion?
A Lancet 2019 series of systematic reviews and meta-analyses found higher fiber and whole-grain intake associated with lower all-cause mortality, cardiovascular outcomes, type 2 diabetes, and colorectal cancer risk, with a practical anchor around 25 to 29 grams of fiber per day.
Use nutrition to change physiology, not to perform identity.
Sleep and sleep apnea
Sleep affects blood pressure, glycemia, appetite, mood, cognition, pain, performance, injury risk, and recovery.
Ask: Do I usually get 7 to 9 hours of sleep opportunity? Is my schedule regular? Do I snore, wake gasping, have witnessed apneas, morning headaches, daytime sleepiness, resistant hypertension, AFib, or central adiposity? Does alcohol, caffeine, light, stress, or schedule chaos explain the problem?
Wearables can help with duration and regularity. They do not diagnose sleep apnea, and their sleep-stage precision is limited. The USPSTF finds insufficient evidence for routine obstructive sleep apnea screening in asymptomatic adults, but symptoms and risk factors should prompt evaluation.
Social connection, hearing, and vision
Social connection is not a wellness platitude. It is health infrastructure.
Ask: Who would notice if something was wrong? Who could I call in a crisis? Do I have recurring in-person contact? Am I lonely, depressed, isolated, grieving, or overloaded as a caregiver? Are hearing or vision problems making me withdraw, fall, or miss information?
Social relationships have been associated with mortality in large meta-analyses. Hearing loss, vision loss, social isolation, hypertension, LDL, diabetes, smoking, alcohol, and head injury also appear in dementia-prevention frameworks.
Make it operational: who, when, how often, and what ritual keeps it alive.
Hormone health belongs, but not as a generic panel
Hormones belong in a longevity audit because transitions can change sleep, mood, bone, muscle, sexual function, fertility, cardiometabolic risk, and day-to-day function. They do not belong as a generic "optimize your hormones" panel for everyone with a credit card.
Make hormone evaluation context-driven:
- Menstrual dysfunction, infertility, PCOS, hyperandrogenic symptoms, heavy bleeding, amenorrhea, or low-energy availability.
- Pregnancy history: gestational diabetes, preeclampsia, gestational hypertension, preterm birth, or recurrent pregnancy loss.
- Perimenopause/menopause symptoms, early menopause, POI, surgical menopause, oophorectomy, cancer treatment, bone risk, or abnormal bleeding.
- Testosterone-deficiency symptoms in men, such as low libido, erectile dysfunction, unexplained anemia, low bone density, infertility concerns, or reduced muscle/strength in the right context.
- Thyroid symptoms or risks, including palpitations, unexplained weight change, heat/cold intolerance, tremor, constipation, goiter, autoimmune history, lithium, or amiodarone.
Menopausal hormone therapy can be appropriate for symptoms and selected risk contexts, especially near menopause, but it should not be sold as generic chronic-disease prevention. The USPSTF recommends against using menopausal hormone therapy solely for primary prevention of chronic conditions. Testosterone diagnosis requires compatible symptoms or signs plus consistently low morning testosterone, not one curiosity lab.
Biomarkers and wearables: use the actionability filter

The best biomarker is the one that changes the next decision.
The best biomarker is not the most obscure one. It is the one that changes the next decision.
High-yield measurements include home blood pressure, LDL-C/non-HDL-C/ApoB, Lp(a) once, A1c or fasting glucose by age/risk, waist or body composition when management-changing, eGFR/uACR in higher-risk people, liver enzymes when alcohol/metabolic/medication context supports it, and CBC/ferritin/B12/TSH/vitamin D only when symptoms or risk make them actionable.
Wearables can help with trends: steps, activity minutes, resting heart rate, estimated fitness, sleep duration, sleep regularity, and HRV as a within-person recovery signal. CGM is high-value for diabetes and selected prediabetes, hypoglycemia, or short experiments; it is not a prerequisite before blood pressure, lipids, activity, strength, nutrition, and sleep. Consumer ECG and AFib alerts can help in older, symptomatic, or higher-risk people, but abnormal alerts need clinical confirmation. Normal wearable data does not rule out disease.
Before tracking anything, ask:
- If this is abnormal, what would I do?
- If it is normal, what would I stop worrying about?
- Could this create false reassurance, false alarms, or an expensive cascade?
- Will tracking this improve behavior or make me more obsessive?
Actionability beats curiosity.
How to personalize the audit
The same checklist should not produce the same order for everyone.
- 20s and 30s: baseline blood pressure, lipids, Lp(a), family history, tobacco/alcohol exposure, fitness, sleep, vaccines, mental health, reproductive goals, and high-exposure risks like driving, biking, sports, shift work, or travel.
- 40s: colorectal screening at 45 for average-risk adults; breast screening, ASCVD risk, ApoB/Lp(a), metabolic risk, perimenopause, body composition, sleep, and selective CAC decisions become more relevant.
- 50s and 60s: lung screening if smoking history qualifies; prostate shared decision-making for many men; menopause, testosterone symptoms, bone density, sleep apnea, vaccines, alcohol, strength, and balance move up.
- 65+: falls, fractures, medication review, hearing, vision, vaccines, frailty, functional strength, cognition, social support, and AAA screening where indicated become central.
- Family and reproductive history: premature ASCVD, sudden death, early cancer, Lynch/BRCA patterns, aneurysm, ADPKD, dementia, familial hypercholesterolemia, high Lp(a), preeclampsia, gestational diabetes, PCOS, early menopause, POI, and surgical menopause can all change the order.
The point is not to build a larger checklist. It is to put the right thing first for the person in front of you.
A simple 30-day longevity audit
Do not overhaul your entire life in one weekend. That is how you create a spreadsheet and then avoid it forever.
- Week 1, collect the facts: home BP average, medication/supplement list, recent lipids/ApoB/Lp(a), A1c/glucose, cancer screening dates, vaccines, smoking, alcohol, sleep, steps, exercise, strength, falls history, and family history.
- Week 2, close overdue loops: schedule overdue screening, follow up abnormal results, confirm high BP properly, and ask whether ApoB, Lp(a), CAC, uACR, DXA, or genetic counseling would change the plan.
- Week 3, install two behaviors: validated BP tracking, two resistance sessions, higher fiber, a higher step floor, a lower-alcohol experiment, a consistent sleep window, or hearing/vision/fall-risk evaluation if relevant.
- Week 4, run one experiment: one question, one intervention, one metric, one decision. Good: "If I increase fiber from 12 to 28 grams per day for 8 weeks, what happens?" Bad: "I will start 12 supplements and see if I feel optimized."
What not to chase first
Lower priority does not mean never. It means not first.
Be cautious about making these the starting point:
- Whole-body MRI as a general screen.
- Broad tumor-marker panels.
- Biological-age clocks.
- Generic hormone panels without symptoms or risk context.
- Microbiome reports that do not change the plan.
- CGM for metabolically healthy people before basics are handled.
- CAC as a universal scan.
- Brain aneurysm screening without high-risk context.
- Supplement stacks before BP, lipids, smoking, alcohol, sleep, strength, and screening.
A good audit is not ascetic. It is ordered.
What to ask your clinician
Bring this as a starter list:
- What is my highest-priority preventable risk right now?
- Is my blood pressure actually controlled based on home or ambulatory data?
- Do my lipids, ApoB, Lp(a), family history, or risk enhancers change my ASCVD plan?
- Am I due for colorectal, breast, cervical, lung, prostate, skin, AAA, HCV, or osteoporosis screening based on my age and risk?
- Do my pregnancy history, PCOS, menopause status, testosterone symptoms, thyroid symptoms, or bone risk change what we should check?
- Do any medications or supplements increase my falls, bleeding, kidney, liver, cognition, or sleep risk?
- Which vaccines am I due for under current CDC guidance?
- What result would change management, and what would we do if it is abnormal?
That last question may be the most important one.
Dr. Hillary Lin’s take
Longevity is not doing everything. It is doing the highest-leverage thing in the right order.
I am not against advanced testing. I am against using advanced testing to avoid the obvious. Most people do not need a more elaborate dashboard before they know their home blood pressure, ApoB, Lp(a), cancer screening status, alcohol pattern, sleep bottleneck, fitness capacity, and family-history risks.
The boring loops are boring because they have been around long enough to accumulate evidence.
Close those first. Then personalize. Then experiment.
Clinical lens
How I’d decide
Use this section as a second pass after the main answer, not as homework before you know what the page is saying.
Who it’s for
Adults who want a systematic preventive health review and are tired of optimization lists that ignore the basics.
Who should skip it
Anyone with chest pain, new neurologic symptoms, syncope, new severe headache, unexplained weight loss, blood in stool, persistent fever, abnormal bleeding, severe depression, or another red flag should not treat this as self-care only; that is medical evaluation.
Measure before / after
Start with home blood pressure, lipid panel with ApoB when useful, Lp(a) once, A1c or fasting glucose by age/risk, cancer screening status, smoking and alcohol exposure, physical activity, strength, sleep, medication and supplement list, and family history.
What I’d do first
Ask what is most likely, preventable, measurable, and action-changing for this person, then close that loop before adding more tracking.
What would change my mind
A test, wearable, supplement, or experiment moves up only if an abnormal or normal result would change an actual decision without creating more harm, false reassurance, false alarms, or obsession than benefit.
Frequently Asked Questions
What is a longevity audit?
A prioritized preventive health review. It ranks actions by absolute risk, preventability, actionability, evidence quality, and personalization instead of novelty.
Where do the hallmarks of aging fit?
They are the mechanism map, not the to-do list. Aging biology matters most when it translates into human, measurable, action-changing proxies.
What should I check first for longevity?
Red-flag symptoms and known abnormal results first. Then blood pressure, cardiovascular risk, tobacco, metabolic risk, age and risk appropriate cancer screening, alcohol, medications, vaccines, fitness, strength, sleep, nutrition, and family history.
Are biomarkers useful for longevity?
Yes, when they change decisions. Home blood pressure, ApoB or LDL-C/non-HDL-C, Lp(a) once, A1c or fasting glucose, eGFR/uACR in risk groups, and DXA when indicated can be high-yield. Broad panels can create noise.
Should I get a whole-body MRI?
Not as the first step for most people. It can find incidental findings and miss other risks. It should not outrank evidence-based screening, blood pressure, lipids, smoking, alcohol, metabolic risk, and cancer screening loops.
Should everyone get hormone testing?
No. Hormone evaluation is most useful when symptoms, transitions, fertility goals, bone risk, menstrual changes, menopause, PCOS, testosterone-deficiency symptoms, thyroid symptoms, or medication context make the result actionable.
Is a CGM worth it if I do not have diabetes?
Sometimes, but usually not first. CGM can help with diabetes, prediabetes, suspected hypoglycemia, or a focused short experiment. For metabolically healthy people, BP, lipids, activity, strength, sleep, nutrition, and alcohol often matter more first.
What is the best wearable for longevity?
For many adults, a validated home blood pressure cuff. Step count, sleep regularity, resting heart rate, estimated fitness, and HRV trends can help behavior, but wearables are not diagnostic tests.
How often should I do a longevity audit?
Yearly, or after major changes: new diagnosis, pregnancy/postpartum transition, menopause, new medication, major weight change, family-history discovery, surgery planning, serious illness, or a big training/lifestyle shift.
References & citations
- 1.CDC/NCHS Mortality in the United States, 2023
- 2.GBD 2021 risk factors, Lancet 2024
- 3.Hallmarks of aging: an expanding universe, Cell 2023
- 4.USPSTF hypertension screening
- 5.USPSTF statin primary prevention
- 6.National Lipid Association Lp(a) focused update
- 7.USPSTF prediabetes and type 2 diabetes screening
- 8.Diabetes Prevention Program, NEJM 2002
- 9.USPSTF colorectal cancer screening
- 10.USPSTF breast cancer screening
- 11.USPSTF cervical cancer screening
- 12.USPSTF lung cancer screening
- 13.USPSTF prostate cancer screening
- 14.USPSTF unhealthy alcohol use screening and counseling
- 15.USPSTF tobacco cessation
- 16.USPSTF falls prevention
- 17.USPSTF osteoporosis screening
- 18.CDC adult immunization schedule
- 19.Endocrine Society testosterone therapy guideline
- 20.NAMS 2022 hormone therapy position statement
- 21.USPSTF menopausal hormone therapy for primary prevention
- 22.USPSTF thyroid dysfunction screening
- 23.International Evidence-Based PCOS Guideline 2023
- 24.AHA Life's Essential 8
- 25.Lancet 2019 fiber and carbohydrate quality review
- 26.BMJ/BJSM 2022 muscle-strengthening activity meta-analysis
- 27.PURE grip strength study, Lancet 2015
- 28.Holt-Lunstad social relationships and mortality meta-analysis
- 29.Lancet Commission dementia prevention 2024
Next step
Turn the guide into the right next decision.
If this page raised a real clinical question, start with the practice details. If you are still learning, get the weekly letter. If you are comparing tests, use the testing hub before buying another panel.